EUVIMEDEUVIMED entdecken
Open Access

TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer

Nuzhat Khursheed, Syed Ishfa Andrabi, Natasha Thakur, Quratul Qadir, Suhail Ashraf, Ambreena Farooq, Safeena Rashid, Farhat Jabeen, Waseen Younis Khan, Allah-U-Deen Khursheed, Mohmmad Afzal Zargar, Asia Asiaf und 1 weitere

Oncotarget · 09.06.2026 · 17 (1) · 316-328

DOI: 10.18632/oncotarget.28891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, erschienen am 09.06.2026. Verfasst von Nuzhat Khursheed und 12 weiteren Autor:innen. Hauptthemen laut MEDLINE: Breast Neoplasms, DNA Methylation, Receptors, TNF-Related Apoptosis-Inducing Ligand, Epigenesis, Genetic. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDNA MethylationReceptors, TNF-Related Apoptosis-Inducing LigandEpigenesis, GeneticGene SilencingHumansFemalePromoter Regions, GeneticGene Expression Regulation, NeoplasticMiddle AgedBiomarkers, TumorAdult

Stichwörter der Autor:innen

TRAIL-R2/DR5apoptotic signalling pathwaysbreast cancer biomarkerspromoter methylationtumor suppressor gene

Substanzen

Receptors, TNF-Related Apoptosis-Inducing LigandTNFRSF10B protein, humanBiomarkers, Tumor

Zitieren

APA

Khursheed, N., Andrabi, S. I., Thakur, N., Qadir, Q., Ashraf, S., Farooq, A., Rashid, S., Jabeen, F., Khan, W. Y., Khursheed, A. U., Zargar, M. A., Asiaf, A., & Ganie, S. A. (2026). TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer. Oncotarget, 17(1), 316-328. https://doi.org/10.18632/oncotarget.28891

Vancouver

Khursheed N, Andrabi SI, Thakur N, Qadir Q, Ashraf S, Farooq A, et al. TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer. Oncotarget. 2026;17(1):316-328. doi:10.18632/oncotarget.28891

BibTeX
@article{Khursheed2026,
  author = {Khursheed, Nuzhat and Andrabi, Syed Ishfa and Thakur, Natasha and Qadir, Quratul and Ashraf, Suhail and Farooq, Ambreena and Rashid, Safeena and Jabeen, Farhat and Khan, Waseen Younis and Khursheed, Allah-U-Deen and Zargar, Mohmmad Afzal and Asiaf, Asia and Ganie, Showkat Ahmad},
  title = {TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {316--328},
  doi = {10.18632/oncotarget.28891}
}
Kostenlos starten →